Eris Lifesciences Limited (NSE:ERIS)
1,321.50
-15.60 (-1.17%)
Nov 19, 2026, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 183.34 billion as of November 19, 2026. It is the 6,415th most valuable company in the world and the 389th biggest in India. Its market cap has decreased by 14.58% in one year.
Market Cap
183.34B
Enterprise Value
205.07B
Revenue
33.12B
Global Rank
Country Rank
#389 India
PE Ratio
25.77
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 183.34B, an increase of 121.68%. That is a compound annual growth rate of 8.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 183.34B | -10.60% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 419.86B |
| Wockhardt | 325.72B |
| Piramal Pharma | 325.58B |
| Alembic Pharmaceuticals | 207.79B |
| Alivus Life Sciences | 177.84B |
| Cohance Lifesciences | 175.08B |
| NATCO Pharma | 162.55B |
| Sudeep Pharma | 132.12B |